Details for New Drug Application (NDA): 201682
✉ Email this page to a colleague
The generic ingredient in LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; losartan potassium. There are thirty-two drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.
Summary for 201682
Tradename: | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
Applicant: | Ipca Labs Ltd |
Ingredient: | hydrochlorothiazide; losartan potassium |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 12.5MG;50MG | ||||
Approval Date: | Mar 1, 2013 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 12.5MG;100MG | ||||
Approval Date: | Mar 1, 2013 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG;100MG | ||||
Approval Date: | Mar 1, 2013 | TE: | AB | RLD: | No |
Complete Access Available with Subscription